Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

HERPERAX TABLET 200 MG - HSA Drug Approval Details

Approvals/HSA/HERPERAX TABLET 200 MG

Approved

THERAPEUTIC

HERPERAX TABLET 200 MG

MICRO LABS LTD (INDIA)🇸🇬 Health Sciences Authority

Approval Date: Mar 19, 1998
Approval ID: ca7d06de3ee3fad2
Company: MICRO LABS LTD (INDIA)
Type: Therapeutic

Approval Details

Approval Id: ca7d06de3ee3fad2
Drug Name: HERPERAX TABLET 200 MG
Product Name: HERPERAX TABLET 200 MG
Approval Number: SIN09682P
Approval Date: 1998-03-19
Registrant: NAINA MOHAMED & SONS PRIVATE LIMITED
Licence Holder: NAINA MOHAMED & SONS PRIVATE LIMITED
Drug Type: Therapeutic
Forensic Classification: PRESCRIPTION ONLY MEDICINES
Dosage Form: TABLET
Route Of Administration: ORAL
Atc Code: J05AB01
Atc Item Name: aciclovir
Pharma Manufacturer Name: NAINA MOHAMED & SONS PRIVATE LIMITED
Company Detail Path: /organization/naina-mohamed-and-sons-private-limited

Active Ingredients

ACYCLOVIR

200 mg

ACYCLOVIR

200 MG

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Mar 19, 1998

Approval ID

ca7d06de3ee3fad2

Type

Therapeutic

Back to HSA Approvals